Share
Back to top
Our Commitment to Innovation
Johnson & Johnson Innovation seeks to positively impact human health through innovation. We do this by helping entrepreneurs realize their dreams of creating healthcare solutions that improve peoples’ lives around the world. We work side-by-side with innovators throughout their journey, providing a robust exchange of ideas and resources to support their success.
The Latest News from Johnson & Johnson Innovation
Our Voices
We aim to build value-creating partnerships with biotech, med tech and health tech startups, entrepreneurs, academics and other partners around the world to change the trajectory of human health.
What we know from the success of our Johnson & Johnson Innovation Centers is that a great idea can come from anywhere, and with the right support, new ideas can be nurtured and translated into meaningful advances in health.
We have unprecedented opportunities and challenges in science and medicine that require an unprecedented approach.
Discover How We Collaborate with External Innovators
Featured Innovation Stories
-
September 15, 2020Cancer. Diabetes. Autoimmune diseases. They're the common illnesses we have a better chance at fighting, thanks to Dr. Cantley's pioneering work. Learn more about his "magic molecule" research.
-
September 08, 2020In signing the pledge, we are joining eight other biopharmaceutical companies working on vaccine research and development in making the safety and well-being of vaccinated individuals our top priority.
-
September 23, 2020First participants dosed in Phase 3 trial (ENSEMBLE) evaluating safety and efficacy of Janssen’s COVID-19 vaccine candidate, JNJ-78436735, also known as Ad26.COV2.S
-
August 11, 2020The company is proud to have made the list for the second year in a row. From its work on an Ebola vaccine—and an investigational COVID-19 vaccine—to collaboration taking place across its Johnson & Johnson Innovation centers, we take a look at the innovative spirit that permeates the company's culture.
-
July 07, 2020The clinical trial has completed full immunizations of the company's investigational HIV vaccine regimen. Learn what this means for the future of fighting the disease—and also for the creation of a potential vaccine for COVID-19.
-
September 08, 2020As part of its new Healthy Lives Mission, the company's iconic consumer brands will aim to use 100% recyclable, reusable or compostable plastic packaging and certified/post-consumer recycled paper- and pulp-based packaging. Learn more about the unique ways the investment will improve the health of people and the earth.
